The Institute for Clinical and Economic Review (ICER) has published its annual report on "unsupported" price increases for ...

Editas ended the third quarter with cash reserves of around $256 million, down from $318 million three months earlier. It ...

Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...

The BBC's probe into Diary of a CEO has followed an increase in emphasis on health topics by Bartlett that, according to the ...

While 2025 remains an unknown quantity, it’s clear that fundraisers and investors see the value in visiting London in ...

Overall, DoE is a valuable approach to improving the quality and efficacy of the final product, streamlining the process, and ...

Sports marketing offers healthcare brands an alternative channel to reach their audiences and align with the strong brand ...

As the current system falters under the weight of inefficient processes and systemic barriers, this is not just a matter of ...

Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker ...

As the healthcare landscape rapidly evolves, staying informed about emerging trends is crucial for driving innovation and ...

The purchase price of the facility was not disclosed, but Lilly says its new $3 billion investment – part of $23 billion ...

A new study has confirmed that the rate of colorectal cancer is rising in younger adults around the world, with England among ...